Collectively, these results indicated that mortalin could regulate the phosphorylation of cancer-associated proteins, and that PI3K/Akt might be a key downstream pathway, regulated by mortalin, in highly angiogenic and sorafenib-resistant HCC cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.